Adoptive transfer data (94) indicated that the combination of carbonic anhydrase IX (CAIX)–chimeric antigen receptor T cell (CAR-T) therapy and sunitinib defensed against lung metastasis of human RCC in a mouse model and improved the survival, but it increased the frequency of T cell infiltration in the TME. This evidence concerns the gene CA9 and renal cell carcinoma.